Literature DB >> 25772322

Cobalamin C Disease Missed by Newborn Screening in a Patient with Low Carnitine Level.

Rebecca C Ahrens-Nicklas1, Esra Serdaroglu, Colleen Muraresku, Can Ficicioglu.   

Abstract

Cobalamin C (CblC) disease is the most common inherited disorder of intracellular cobalamin metabolism. It is a multisystemic disorder mainly affecting the eye and brain and characterized biochemically by methylmalonic aciduria, low methionine level, and homocystinuria. We report a patient found to have CblC disease who initially presented with low carnitine and normal propionylcarnitine (C3) levels on newborn screen. Newborn screening likely failed to detect CblC in this patient because of both his low carnitine level and the presence of a mild phenotype.

Entities:  

Year:  2015        PMID: 25772322      PMCID: PMC4484904          DOI: 10.1007/8904_2015_429

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  24 in total

1.  Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.

Authors:  D H Chace; J C DiPerna; T A Kalas; R W Johnson; E W Naylor
Journal:  Clin Chem       Date:  2001-11       Impact factor: 8.327

2.  Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations.

Authors:  Chantal F Morel; Jordan P Lerner-Ellis; David S Rosenblatt
Journal:  Mol Genet Metab       Date:  2006-05-22       Impact factor: 4.797

Review 3.  Carnitine deficiency disorders in children.

Authors:  Charles A Stanley
Journal:  Ann N Y Acad Sci       Date:  2004-11       Impact factor: 5.691

4.  Two-tier approach to the newborn screening of methylenetetrahydrofolate reductase deficiency and other remethylation disorders with tandem mass spectrometry.

Authors:  Silvia Tortorelli; Coleman T Turgeon; James S Lim; Steve Baumgart; Debra-Lynn Day-Salvatore; Jose Abdenur; Jonathan A Bernstein; Fred Lorey; Uta Lichter-Konecki; Devin Oglesbee; Kimiyo Raymond; Dietrich Matern; Lisa Schimmenti; Piero Rinaldo; Dimitar K Gavrilov
Journal:  J Pediatr       Date:  2010-04-14       Impact factor: 4.406

Review 5.  Cobalamin C defect: natural history, pathophysiology, and treatment.

Authors:  Diego Martinelli; Federica Deodato; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2010-07-15       Impact factor: 4.982

6.  Retinal Structure in Cobalamin C Disease: Mechanistic and Therapeutic Implications.

Authors:  Tomas S Aleman; Frank Brodie; Christopher Garvin; Dina Y Gewaily; Can H Ficicioglu; Monte D Mills; Brian J Forbes; Albert M Maguire; Stefanie L Davidson
Journal:  Ophthalmic Genet       Date:  2014-02-10       Impact factor: 1.803

7.  Carnitine concentrations in term and preterm newborns at birth and during the first days of life.

Authors:  T Honzík; R Chrastina; H Hansíková; M Böhm; O Martincová; R Plavka; M Zapadlo; J Zeman
Journal:  Prague Med Rep       Date:  2005

8.  The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum.

Authors:  C Thauvin-Robinet; E Roze; G Couvreur; M-H Horellou; F Sedel; D Grabli; G Bruneteau; C Tonneti; A Masurel-Paulet; D Perennou; T Moreau; M Giroud; H Ogier de Baulny; S Giraudier; L Faivre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-01       Impact factor: 10.154

9.  Long-term outcome in treated combined methylmalonic acidemia and homocystinemia.

Authors:  H C Andersson; M Marble; E Shapira
Journal:  Genet Med       Date:  1999 May-Jun       Impact factor: 8.822

Review 10.  Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy.

Authors:  Martina Huemer; Sabine Scholl-Bürgi; Karine Hadaya; Ilse Kern; Ronny Beer; Klaus Seppi; Brian Fowler; Matthias R Baumgartner; Daniela Karall
Journal:  Orphanet J Rare Dis       Date:  2014-11-15       Impact factor: 4.123

View more
  5 in total

1.  Milder clinical and biochemical phenotypes associated with the c.482G>A (p.Arg161Gln) pathogenic variant in cobalamin C disease: Implications for management and screening.

Authors:  Mohammed Almannai; Ronit Marom; Kristian Divin; Fernando Scaglia; V Reid Sutton; William J Craigen; Brendan Lee; Lindsay C Burrage; Brett H Graham
Journal:  Mol Genet Metab       Date:  2017-06-29       Impact factor: 4.797

2.  Expanded Screening of One Million Swedish Babies with R4S and CLIR for Post-Analytical Evaluation of Data.

Authors:  Lene Sörensen; Ulrika von Döbeln; Henrik Åhlman; Annika Ohlsson; Martin Engvall; Karin Naess; Carolina Backman-Johansson; Yvonne Nordqvist; Anna Wedell; Rolf H Zetterström
Journal:  Int J Neonatal Screen       Date:  2020-05-27

3.  The Follow-Up of Chinese Patients in cblC Type Methylmalonic Acidemia Identified Through Expanded Newborn Screening.

Authors:  Shiying Ling; Shengnan Wu; Ruixue Shuai; Yue Yu; Wenjuan Qiu; Haiyan Wei; Chiju Yang; Peng Xu; Hui Zou; Jizhen Feng; Tingting Niu; Haili Hu; Huiwen Zhang; Lili Liang; Deyun Lu; Zhuwen Gong; Xia Zhan; Wenjun Ji; Xuefan Gu; Lianshu Han
Journal:  Front Genet       Date:  2022-02-15       Impact factor: 4.599

4.  Clinical, phenotypic and genetic landscape of case reports with genetically proven inherited disorders of vitamin B12 metabolism: A meta-analysis.

Authors:  Arnaud Wiedemann; Abderrahim Oussalah; Nathalie Lamireau; Maurane Théron; Melissa Julien; Jean-Philippe Mergnac; Baptiste Augay; Pauline Deniaud; Tom Alix; Marine Frayssinoux; François Feillet; Jean-Louis Guéant
Journal:  Cell Rep Med       Date:  2022-06-27

5.  Efficacy of early treatment in patients with cobalamin C disease identified by newborn screening: a 16-year experience.

Authors:  Rebecca C Ahrens-Nicklas; Ashley M Whitaker; Paige Kaplan; Sanmati Cuddapah; Jessica Burfield; Jennifer Blair; Ligia Brochi; Marc Yudkoff; Can Ficicioglu
Journal:  Genet Med       Date:  2017-02-02       Impact factor: 8.822

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.